| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $40.5M | +7.4% |
| Cost of Revenue | $27.1M | -11.3% |
| Gross Profit | $13.4M | +85.9% |
| R&D Expense | $2.2M | -20.4% |
| SG&A Expense | $20.3M | -12.2% |
| Operating Income | -$17.0M | +35.1% |
| Pre-tax Income | -$17.2M | +35.9% |
| Income Tax | $58K | +165.9% |
| Net Income | -$17.3M |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $5.9M | +59.4% |
| Short-term Investments | $15.4M | -42.2% |
| Accounts Receivable | $4.6M | +7.1% |
| Inventory | $7.1M | +3.7% |
| Current Assets | $34.5M | -19.3% |
| Total Assets | $103.6M | -12.8% |
| Current Liabilities | $7.5M | -32.8% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$8.6M | +30.2% |
| Capital Expenditures | $1.1M | +2.0% |
| Investing Cash Flow | $10.7M | +139.2% |
| Financing Cash Flow | $151K | -99.0% |
| Free Cash Flow | -$9.8M | +27.5% |
| +35.5% |
| EPS (Basic) | -$0.32 | +43.9% |
| EPS (Diluted) | -$0.32 | +43.9% |
| Long-term Debt |
| $13.1M |
| +39.0% |
| Total Liabilities | $34.8M | -4.3% |
| Stockholders' Equity | $68.8M | -16.5% |